Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fli-HA platform-based ophthalmology product
- Development stage
- Preclinical
- Lead developer
- Fount Bio
- Modality
- Hydrogel Systems → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic, Intravitreal, Subconjunctival
01
Overview
The Fli-HA platform-based ophthalmology product is an investigational drug delivery system developed by Fount Bio. It utilizes the proprietary Flī-HA™ technology, which is based on bioorthogonal chemistry and glycopolymer science to create durable forms of hyaluronic acid (HA) for medical applications. The core mechanism involves enabling tailored placement and prolonged retention of large glycopolymers like HA onto or within ocular tissues, potentially improving drug residence time, controlled release, and tissue hydration in the eye. This approach aims to overcome key challenges in delivering therapeutics for various ocular diseases by leveraging HA’s biocompatibility, viscoelasticity, and mucoadhesive properties[1][2][3]. While specific indications are not yet disclosed for this particular product, HA-based platforms are widely researched for conditions such as dry eye syndrome, glaucoma, retinal disorders, and ocular infections.
- Other names
- Flī-HA ophthalmology product
Beyond the preview
Go deeper on Fli-HA platform-based ophthalmology product.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fli-HA platform-based ophthalmology product.